×
Skip to content
ShareCafe

  • Home
  • Shares
  • Advice
  • Wealth
    • Wealth Home
    • Product Profiles
  • Property
  • Video
  • Contributors
  • Community
  • About us
  • Facebook
  • Twitter
  • YouTube
  • RSS
Main Menu

Tag: ASIA

Etfs / Funds / Markets

U.S. Elections: what does the ‘blue wave’ mean for investors?

January 13, 2021 - by BetaShares

by Adam O’Connor

Read More
Etfs / Funds

Core strength: working the abs of your investment portfolio

November 19, 2020 - by BetaShares

A well-diversified portfolio can assist with reducing volatility and enhancing performance returns.

Read More
Etfs / Funds

U.S. election: Three possible scenarios, and ways investors could play them

October 28, 2020 - by BetaShares

With the U.S. Presidential election now less than a week away, many investors are currently considering how the potential result could impact their portfolios.

Read More
Etfs / Funds

Asian Tech: Tiger Amongst The Bears

September 3, 2020October 28, 2020 - by BetaShares

As we enter the second half of 2020, it’s clear that the steady sharemarket rise of the last 10 years has ended, and we are in a new time of volatility and uncertainty. Following the historic market sell-off in Q1 and subsequent recovery in Q2, markets have largely laid flat and trended sideways for the past few weeks.

Read More
  • US Political Protests, Inflation and Rising Bond Yields
  • Huge Week for Netflix as Shares Touch Record High
  • Is it Time to Buy Airports and Toll Road Companies?
  • Little to Cheer About as Xmas Retail Spending Slumps
  • Evening Report: ASX eases into the weekend
  • CCL Slightly Exceeds Expectations but Indonesia Still a Worry
  • COVID Still Driving FPH Revenue as Earnings Surge
  • RMD – UBS rates the stock as Buy

Subscribe to ShareCafe

The daily resource for hands-on investors. Market insights and investment ideas delivered free to your inbox.

Copyright 2020 Informed Investor Pty Ltd ABN 42 162 871 589. All rights reserved.
No portion of this website maybe reproduced, copied or in any way released without written permission.
Share Cafe is a Corporate Authorised Representative (001283561) of PacReef Asset Management Pty Ltd who holds an Australian Financial Services Licence (Number: 488045)

Terms of Service | Financial Services Guide | Privacy Policy | Contact | Advertise

DOWNLOAD RESEARCH REPORT

And a Door Opens Wide

Antisense Therapeutics’ lead drug sits at the nexus of two areas of drug development that are starting to grow dramatically in importance. One relates to its mode of action and the other to the type of drug it is. Combine that with management who know the drug very well and strong results in a trial in a horrible disease afflicting children, and you have the basis for true value creation.

SMSFBrokerFinancial AdviserRetail Investor

Please prove you are human by selecting the Heart.


DOWNLOAD RESEARCH REPORT

Fit for tough times; prepared for coal’s upswing

Terracom has counter-cyclically placed itself in a position to improve efficiency and margins plus pursue organic mine growth. Cashflows will further swell once currently depressed coal prices rebound. These assets appear undervalued compared to our Base Case $0.27/share NPV valuation of TER. TER has upside on management’s record of delivering new projects from currently controlled development assets and/or by opportunistically securing acquisitions.

SMSFBrokerFinancial AdviserRetail Investor

Please prove you are human by selecting the Car.

DOWNLOAD RESEARCH REPORT

A Laser-Like Focus on Adding Value

Since August 1st, Kazia Therapeutics has announced US Food & Drug Administration fast track status for one program & orphan drug and rare paediatric disease designation for another, while finishing the period by announcing a new trial for its cancer drug, paxalisib. Over the next nine months investors are likely to see six data readouts from five programs. How fast can a company go?

SMSFBrokerFinancial AdviserRetail Investor

Please prove you are human by selecting the Cup.